Showing results (1211-1220 of 2,366) with videos related to
Sort By:
Pageof 237
Nucleic Acids Research|July 25, 1994
Site-specific targeting of psoralen photoadducts with a triple helix-forming oligonucleotide: characterization of psoralen monoadduct and crosslink formationF P Gasparro, P A Havre, G A Olack, et al.Oncotarget|March 1, 2018
MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironmentHongyan Yuan, Xiaoyi Wang, Jin Lu, et al.Oncotarget|February 1, 2019
Correction: MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironmentHongyan Yuan, Xiaoyi Wang, Jin Lu, et al.Journal of Human Hypertension|July 21, 2001
Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril aloneJ Pool, P Kaihlanen, G Lewis, et al.Biochemical Pharmacology|December 1, 1982
Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivoH N Jayaram, A L Smith, R I Glazer, et al.Nauchnye Doklady Vysshei Shkoly. Biologicheskie Nauki|January 1, 1983
[Test-systems for biomonitoring based on membrane-bound enzyme complexes. III. An assessment of the genotoxic action of industrial effluents in the Ames test-system with metabolic activation by microsomal monooxygenases]V M Glazer, V E Kagan, S K Abilev, et al.The Journal of Biological Chemistry|March 3, 1995
Regulation of HIV-1 gag protein subcellular targeting by protein kinase CG Yu, F S Shen, S Sturch, et al.Ophthalmic Plastic and Reconstructive Surgery|January 1, 1991
Mechanisms of visual loss in severe proptosisP J Dolman, L C Glazer, G J Harris, et al.Circulation. Genomic and Precision Medicine|May 6, 2018
SCN5A (NaV1.5) Variant Functional Perturbation and Clinical Presentation: Variants of a Certain SignificanceBrett M Kroncke, Andrew M Glazer, Derek K Smith, et al.European Journal of Medicinal Chemistry|July 29, 2018
Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolinesDmytro Havrylyuk, Brock S Howerton, Leona Nease, et al.Pageof 237